VX-759

• Description :

  VX-759 (VCH-759) is an orally active HCV NS5B RNA-dependent RNA polymerase inhibitor. VX-759 is promising for research of chronic hepatitis C[1].

• Product Name Alternative :

  VCH-759

• UNSPSC :

  12352005

• Hazard Statement :

  H302-H315-H319-H335

• Target :

  HCV; HCV Protease

• Related Pathways :

  Anti-infection; Metabolic Enzyme/Protease

• Applications :

  COVID-19-anti-virus

• Field of Research :

  Infection

• Smiles :

  O=C([C@@H]1CC[C@H](CC1)C)N(C2=C(SC(C3=CC=CC=C3)=C2)C(O)=O)C(C)C

• Molecular Formula :

  C22H27NO3S

• Molecular Weight :

  385.52

• Precautions :

  P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

• References & Citations :

  [1]Cooper C, et al. Evaluation of VCH-759 monotherapy in hepatitis C infection. J Hepatol. 2009 Jul;51 (1) :39-46. doi: 10.1016/j.jhep.2009.03.015. Epub 2009 Apr 23.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [478025-29-5]